Cargando…

M217. EFFICACY OF PALIPERIDONE PALMITATE ON PSYCHIATRIC SYMPTOMS AND ATTITUDES TOWARD MEDICATION IN SCHIZOPHRENIA

Abstract not included.

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session II
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234496/ http://dx.doi.org/10.1093/schbul/sbaa030.529

Ejemplares similares

M197. SEASONAL ANTIPSYCHOTICS IN SCHIZOPHRENIA: OUTCOMES IN NATURALISTIC SETTINGS (SEASONS STUDY) OBSERVATIONAL RETROSPECTIVE MULTICENTRE CANADIAN STUDY ON 3MONTH-FORMULATION OF LONG-ACTING INJECTABLE PALIPERIDONE PALMITATE
por: Corbeil, Olivier, et al.
Publicado: (2020)

M54. ASSOCIATIONS BETWEEN MUSICAL ABILITY SUBSCALE PERFORMANCE, PSYCHIATRIC SYMPTOMS, AND COGNITIVE FUNCTIONING IN SCHIZOPHRENIA
por: Akagawa, Yoshiki, et al.
Publicado: (2020)

S56. SWITCHING FROM RISPERIDONE TO PALIPERIDONE PALMITATE IN SCHIZOPHRENIA: CHANGES IN COGNITIVE FUNCTION
por: Tost Bonet, Meritxell, et al.
Publicado: (2020)

T211. COMPARISON OF REHOSPITALIZATION RATE IN INDIVIDUALS WITH SCHIZOPHRENIA CHANGED FROM PALIPERIDONE PALMITATE TO ORAL ANTIPSYCHOTICS
por: Ju Lee, Bong, et al.
Publicado: (2020)

M234. QUALITY OF LIFE IN SCHIZOPHRENIA: THE IMPACT OF RESIDUAL SYMPTOMS AND INTERNALIZED STIGMA
por: Hofer, Alex, et al.
Publicado: (2020)

M224. LONGITUDINAL DETERIORATION OF GESTURE PERFORMANCE IN SCHIZOPHRENIA IS UNRELATED TO SYMPTOM TRAJECTORIES
por: Pavlidou, Anastasia, et al.
Publicado: (2020)

M184. SOCIAL SKILLS TRAINING FOR TREATMENT-RESISTANT SCHIZOPHRENIA WITH PREDOMINANTLY NEGATIVE SYMPTOMS
por: Kayo, Monica, et al.
Publicado: (2020)

M216. ASSOCIATIONS OF EXTRAPYRAMIDAL SYMPTOMS WITH PSYCHOTIC SYMPTOMS IN A COHORT OF HOMELESS OR PRECARIOUSLY HOUSED PERSONS WITH OR WITHOUT SCHIZOPHRENIA
por: Kim, David, et al.
Publicado: (2020)

M157. A MULTICENTRE STUDY OF 1H-MRS BRAIN GLUTAMATE LEVELS IN SCHIZOPHRENIA; INVESTIGATING THE EFFECT OF ANTIPSYCHOTIC MEDICATION, SYMPTOM SEVERITY AND AGE
por: Merritt, Kate, et al.
Publicado: (2020)

S203. EFFECT OF LONG-ACTING INJECTIONS OF PALIPERIDONE PALMITATE ON CLINICAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH SCHIZOPHRENIA BASED ON ILLNESS DURATION
por: Kim, Seoyoung, et al.
Publicado: (2020)

M39. AN UPDATE ON THE EFFICACY OF ANTI-INFLAMMATORY AGENTS FOR PATIENTS WITH SCHIZOPHRENIA: A META-ANALYSIS
Publicado: (2020)

M51. EFFICACY OF “PRAGMACOM TRAINING” IN SCHIZOPHRENIA: A RCT ON A NOVEL PRAGMATIC INTERVENTION
por: Agostoni, Giulia, et al.
Publicado: (2020)

M124. ASSOCIATION OF CHRONIC PHYSICAL MULTIMORBIDITY WITH THE EFFICACY OF TREATMENT IN DIFFERENT SCHIZOPHRENIA SPECTRUM DISORDERS
por: Filipčić, Igor, et al.
Publicado: (2020)

M125. DISEASE PREVALENCE, COMORBID CONDITIONS, AND MEDICATION UTILIZATION AMONG PATIENTS WITH SCHIZOPHRENIA IN THE UNITED STATES
por: Roy, Brittany, et al.
Publicado: (2020)

M152. IS MEDICAL SERVICES UTILISATION A MODERATING FACTOR OF EARLY EXCESS MORTALITY IN PATIENTS WITH SCHIZOPHRENIA
por: Krivoy, Amir, et al.
Publicado: (2020)

M44. COGNITIVE REMEDIATION AND PHYSICAL EXERCISE EFFECTS ON NEGATIVE SYMPTOMS AND FUNCTIONALITY IN PATIENTS WITH SCHIZOPHRENIA: A RANDOMIZED CONTROLLED TRIAL
por: Mane, Anna, et al.
Publicado: (2020)

M73. DRIVING ABILITIES IN PATIENTS WITH SCHIZOPHRENIA
por: Pardeller, Silvia, et al.
Publicado: (2020)

M190. USE OF NULL PRONOUNS IN SCHIZOPHRENIA
por: Chaves, Monica, et al.
Publicado: (2020)

M168. CLINICAL-ANATOMICAL PHENOTYPES OF SCHIZOPHRENIA
por: Kirschner, Matthias, et al.
Publicado: (2020)

M109. WEIGHT GAIN AND THE PATHOPHYSIOLOGY OF SCHIZOPHRENIA
Publicado: (2020)

T201. EFFECTS OF PALIPERIDONE PALMITATE ON HEALTHCARE UTILIZATION AND COSTS FOR PATIENTS WITH SCHIZOPHRENIA: A CLAIM-BASED MIRROR-IMAGE STUDY IN SOUTH KOREA
por: Hun Jung, Myung, et al.
Publicado: (2020)

S200. COMPARISON BETWEEN LONG-ACTING INJECTABLE ARIPIPRAZOLE VERSUS PALIPERIDONE PALMITATE IN THE TREATMENT OF SCHIZOPHRENIA: SYSTEMATIC REVIEW AND INDIRECT TREATMENT COMPARISON
Publicado: (2020)

M64. ADDRESSING THE ROLE OF TIMING ON COGNITION IN SCHIZOPHRENIA
por: Alústiza, Irene, et al.
Publicado: (2020)

M117. ELUCIDATING ARCHITECTURE OF NEGATIVE SYNDROME IN SCHIZOPHRENIA
por: San Ang, Mei, et al.
Publicado: (2020)

M245. AN RCT PROTOCOL OF HYBRID-ECT FOR SCHIZOPHRENIA
por: Rong, Han
Publicado: (2020)

M198. INVESTIGATIONAL DOPAMINE ANTAGONISTS FOR THE TREATMENT OF SCHIZOPHRENIA
Publicado: (2020)

M222. SURVEY RESULTS FROM TURKEY: KNOWLEDGE ABOUT SCHIZOPHRENIA, PUBLIC STIGMA AND DISCRIMINATION BECAUSE OF SCHIZOPHRENIA
por: Haldun, Soygur, et al.
Publicado: (2020)

M106. VIRTUAL-REALITY COGNITIVE TRAINING AND ASSESSMENT IN SCHIZOPHRENIA
por: Porffy, Lilla, et al.
Publicado: (2020)

M215. FACTORS ASSOCIATED WITH CLOZAPINE RESPONSE AND RESISTANCE IN SCHIZOPHRENIA
por: Lee, Jimmy, et al.
Publicado: (2020)

M55. STRUCTURAL CHANGES RELEVANT TO MUSICAL DEFICITS IN SCHIZOPHRENIA
por: Sawada, Ken, et al.
Publicado: (2020)

M228. THE EFFECT OF SOCIALIZATION ON ANTICIPATORY AND CONSUMMATORY PLEASURE IN SCHIZOPHRENIA
por: Merchant, Jaisal, et al.
Publicado: (2020)

Racial differences in attitudes toward COVID-19 vaccination during pregnancy
por: Binger, Kole S., et al.
Publicado: (2022)

M67. UNDERSTANDING SOCIAL COGNITION IN SCHIZOPHRENIA THROUGH THE LENS OF SCHIZOTYPY
por: Lee, Sara-Ann, et al.
Publicado: (2020)

M41. TRAJECTORIES AND PREDICTORS OF OUTCOME IN SCHIZOPHRENIA: THE BENEFICIAL ROLE OF AMISULPRIDE
por: Drosos, Petros, et al.
Publicado: (2020)

M243. EFFECTIVENESS AND SATISFACTION WITH A SCHIZOPHRENIA RECOVERY DAY PROGRAM
por: Murata, Lisa, et al.
Publicado: (2020)

M13. INCREASED SAFETY SEEKING IN PATIENTS WITH SCHIZOPHRENIA AND PARANOID THREAT
por: Gangl, Nicole, et al.
Publicado: (2020)

M120. IMPAIRED CLINICAL INSIGHT AS A PREDICTOR OF RELAPSE IN SCHIZOPHRENIA
por: Lindenmayer, Jean-Pierre, et al.
Publicado: (2020)

M75. INCREASED REPULSION OF VISUAL WORKING MEMORY REPRESENTATIONS IN SCHIZOPHRENIA
Publicado: (2020)

M69. IMPROVING VISUAL ATTENTION TO SOCIAL STIMULI IN INDIVIDUALS WITH SCHIZOPHRENIA
por: Klein, Hans, et al.
Publicado: (2020)

M68. COGNITIVE IMPAIRMENT IN NEVER-TREATED SCHIZOPHRENIA SPECTRUM INDIVIDUALS
por: Solis-Vivanco, Rodolfo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qflmjp4dq2p9l3rdum61p74heb